PHARMADVANCE
Timeline
17 events since 2017Board
Filings
Financial
Establishments
20182020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBabbreviated format · 23 days before the deadline
2025
Annual accounts 2024 filed PDFfull format · 21 days late
2024
Annual accounts 2023 filed PDFfull format · 84 days late
2023
Registered in the Peppol Directory Reachable for e-invoices through 0208:0671818337
Annual accounts 2022 filed PDFfull format · 90 days late
Changes of role: BLUESTONE (director) and HP PHARMA (director)Permanent representatives: Paul RANSART and Stéphanie THOMAES · “1) l'exploitation d'officines pharmaceutiques dans le respect des règles édictées par l'Ordre des…” (deed in French) · Director discharge: BLUESTONE · General meeting of 10-07-202311 points ▸
- 100 shares
- General meeting, 10-07-2023
- Director resignation, BLUESTONE (manager)
- Director resignation, HP PHARMA (manager)
- Director appointment, BLUESTONE (director (not named in the articles))
- Director appointment, HP PHARMA (director (not named in the articles))
- Permanent representative, Paul RANSART
- Permanent representative, Stéphanie THOMAES
- Director discharge, BLUESTONE
- Director discharge, HP PHARMA
- Registered office clause, Rue de l'Eglise 48
- The deed holds 6 more points.
2022
Annual accounts 2021 filed PDFfull format · 33 days late
2 directors appointed, 2 resignationsResignations: Paul RANSART and PHARMACOACH · Permanent representatives: Stephanie THOMAES and Paul RANSART · Appointments: BLUESTONE and HP PHARMA · General meeting of 16-06-20227 points ▸
- General meeting, 16-06-2022
- Director resignation, Paul RANSART
- Director resignation, PHARMACOACH
- Permanent representative, Stephanie THOMAES, mentioned twice in the deed
- Director appointment, BLUESTONE
- Permanent representative, Paul RANSART
- Director appointment, HP PHARMA
2021
Highest result from 2017 to 2025 net €70,183 ▲44% The operating result of €71,457 and the net result of €70,183 are both a record.
Annual accounts 2020 filed PDFfull format · 61 days late
2020
Back to profit net €48,741 The net result is €48,741, after 3 loss-making years.
Annual accounts 2019 filed PDFfull format · 17 days late
2019
Annual accounts 2018 filed PDFfull format · 27 days late
2018
Annual accounts 2017 filed PDFfull format · 30 days late
2017
New establishment in Leuze-en-Hainaut Pharmacie de la Grand-Place, Grand-Place 15
Incorporation PDFpublished on 28-02-2017
First establishment Rue de l'Eglise 48, Chièvres
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank